Genomic analysis of the international high-risk clonal lineage Klebsiella pneumoniae sequence type 395.

Autor: Shaidullina ER; Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia., Schwabe M; Pharmaceutical Microbiology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany., Rohde T; Pharmaceutical Microbiology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany., Shapovalova VV; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Dyachkova MS; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Matsvay AD; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Savochkina YA; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Shelenkov AA; Central Research Institute of Epidemiology, Moscow, Russia., Mikhaylova YV; Central Research Institute of Epidemiology, Moscow, Russia., Sydow K; Pharmaceutical Microbiology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany., Lebreton F; Multidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, USA., Idelevich EA; Friedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, Greifswald, Germany.; Institute of Medical Microbiology, University Hospital Münster, Münster, Germany., Heiden SE; Pharmaceutical Microbiology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany., Becker K; Friedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, Greifswald, Germany., Kozlov RS; Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia., Shipulin GA; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Akimkin VG; Central Research Institute of Epidemiology, Moscow, Russia., Lalk M; Institute of Biochemistry, University of Greifswald, Greifswald, Germany., Guenther S; Pharmaceutical Biology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany., Zautner AE; Institute of Medical Microbiology and Hospital Hygiene, Medical Faculty, Otto-Von-Guericke University Magdeburg, Magdeburg, Germany., Bohnert JA; Friedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, Greifswald, Germany., Mardanova AM; Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia., Bouganim R; Department of Internal Medicine A, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel., Marchaim D; Infection Control Unit, Shamir (Assaf Harofeh) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Hoff KJ; Institute of Mathematics and Computer Science, University of Greifswald, Greifswald, Germany., Schaufler K; Pharmaceutical Microbiology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany. schaufler@infmed.uni-kiel.de.; Institute of Infection Medicine, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany. schaufler@infmed.uni-kiel.de., Edelstein MV; Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia.

Publikováno v: Genome medicine [Genome Med] 2023 Feb 13; Vol. 15 (1), pp. 9. Date of Electronic Publication: 2023 Feb 13.